In 2023, ScinoPharm Taiwan conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2023 | 2022 |
|---|---|---|
Total Waste Generated | 4,073.016a | 2,834.473a |
Total Waste Recovered | 1,074.736a | 673.911a |
Total Hazardous Waste Generated | 3,647.66a | 2,518.956a |
Non-Hazardous Waste Disposed | 415.88a | 306.956a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2023, ScinoPharm Taiwan generated a total of 4,073metric tonnes of waste.a
Of this amount, 26.39% of ScinoPharm Taiwan's total waste generated was recovered through methods such as recycling, reuse, or composting, while 73.61% was disposed of through landfilling, incineration, or combustion.a
In 2023, ScinoPharm Taiwan reported a total waste generation of 4,073 metric tonnes, of which 26.39% was recovered through recycling, reuse, or composting.This moderate level of recovery indicates that ScinoPharm Taiwan is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.a
Since 2023, ScinoPharm Taiwan's total waste generation has increased by 43.7%, which may reflect expanding operations, weaker material efficiency, or insufficient waste reduction efforts.a
Over the same period, ScinoPharm Taiwan's waste recovery rate increased by 10.98%.a
In 2023, ScinoPharm Taiwan generated a total of 4,073 metric tonnes of waste.a
Of this amount, 89.56% of ScinoPharm Taiwan's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment.10.44% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.a
Since 2023, ScinoPharm Taiwan's total waste generation has increased by 43.7%, which may reflect expanding operations, weaker material efficiency, or insufficient waste reduction efforts.a
Since 2023, ScinoPharm Taiwan's hazardous waste generation has increased by 0.77%, indicating a potential rise in the use of harmful materials, process inefficiencies, or limited hazardous waste reduction strategies..a
Overall, ScinoPharm Taiwan's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.a
In 2023, ScinoPharm Taiwan reported that 3,648 metric tonnes of its total waste output were classified as hazardous. This represents 89.56% of its overall waste generation.a
The company treated this hazardous waste using a combination of methods.Approximately 29.2% was managed through recovery methods, indicating a moderate integration of circular practices into its hazardous waste management. However, a significant share was still directed toward disposal, highlighting room for improvement in reducing the long-term impact of hazardous materials.a